Skip to content

Clinical trials

Observational Liver Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Observational Country / region: United States Clear all

111 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20033
20046
20051
20061
20072
20087
20098
20106
20114
20124
20133
20143
20152
20166
20174
20186
20194
20205
20217
20227
20232
20244
20258
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Recruiting23
Terminated15
Active, not recruiting6
Unknown status4
Withdrawn4
Enrolling by invitation2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)9
Northwestern University6
City of Hope Medical Center5
Mayo Clinic5
Pathfinder Therapeutics5
Memorial Sloan Kettering Cancer Center4
Stanford University4
Bayer3
M.D. Anderson Cancer Center3
Wake Forest University Health Sciences3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms111
Carcinoma, Hepatocellular40
Pancreatic Neoplasms26
Lung Neoplasms21
Neoplasms20
Stomach Neoplasms19
Esophageal Neoplasms18
Urinary Bladder Neoplasms16
Prostatic Neoplasms15
Breast Neoplasms14

Trials

Showing 1 to 25 of 111. Each trial links to its page on Pharma Observatory.

11 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.